ArticleJHEP reports : innovation in hepatology2023

A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease.

Adel Hammoutene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.